Skip to content

Drug interactions

Apalutamide + Zafirlukast

Severity: Moderate

Apalutamide and Zafirlukast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide is a weak inducer of CYP2C9 and can lower the plasma concentration of zafirlukast, which is cleared mainly by CYP2C9. Reduced exposure may weaken control of asthma symptoms.

What this interaction means in plain words

Apalutamide and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Apalutamide belongs to Endocrine; Zafirlukast belongs to Respiratory.

Evidence level: Moderate

Why it happens

Apalutamide induces CYP2C9 (and CYP3A4), increasing the hepatic metabolism of zafirlukast.

What to do

Monitor asthma control and watch for loss of zafirlukast effect when apalutamide is started. Consider an alternative controller or dose reassessment if control worsens.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Zafirlukast?

MediHelp rates the interaction as moderate. Apalutamide and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Apalutamide is a weak inducer of CYP2C9 and can lower the plasma concentration of zafirlukast, which is cleared mainly by CYP2C9. Reduced exposure may weaken control of asthma symptoms.

How serious is the interaction between Apalutamide and Zafirlukast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor asthma control and watch for loss of zafirlukast effect when apalutamide is started. Consider an alternative controller or dose reassessment if control worsens.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in